What's new

PSUSA/00000434/202407

PSUSA/00000434/202407

Feb 19, 2025 - 17:08
 0
PSUSA/00000434/202407
PSUSA/00000434/202407
Read More

Tags:

Previous Article

Opinion/decision on a Paediatric investigation plan (PIP): Feraccru, ferric malt...

Next Article

EVIQO Level 2: Reliable Home EV Charging Solutions

Related Posts

Article 57 product data

Feb 14, 2025  0

Human medicines European public assessment report (EPAR): Remicade, infliximab, Date of authorisation: 13/08/1999, Revision: 66, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 9, 2025  0

Budesonide, gastro-resistant hard capsules, 3 mg, gastro- resistant granules, 9 mg product-specific bioequivalence guidance

Budesonide, gastro-resistant hard capsules, 3 mg, gastr...

Feb 12, 2025  0